Mesothelioma is one of the deadliest diseases known to man; the average life span of an inflicted person from the time of diagnosis until death is less than 24 months. It’s a disease that strikes approximately 3,000 United States citizens each and every year; hard working people who have labored for a lifetime to provide for their families, doing the work that keeps this country running and a great place to live. They worked in factories, at shipyards, in mines, for the US military, as engineers, as pipefitters, as steel workers, as auto mechanics, and in so many other professions.

Mesothelioma is a rare and virulent form of cancer that affects the lining of the lung, lining of the abdominal cavity or lining around the heart. Mesothelioma is caused by exposure to asbestos, and occurs in those who have breathed in asbestos fiber, in many cases 20 to 50 or more years ago. Some were exposed on their jobs; others were exposed secondarily through family members who without their knowledge, brought fiber home on their work clothes or on their hair or skin.

Despite the serious nature of the disease, there is hope. Every year, doctors and scientists worldwide are developing new treatments and making new discoveries that help to improve the chance of survival and the patient’s quality of life. This website, Beat Mesothelioma, helps patients and their family members connect with the resources they need to be informed and make the best decisions on their potential treatment and care.

The first section of our website answers common questions about Mesothelioma and its cause and discusses those at risk. In the next section, the most common symptoms are discussed, as well as the various testing procedures which may be used to come to a diagnosis. The treatment section discusses types of aggressive treatment such as surgery, chemotherapy, radiation and clinical trials being conducted by cancer facilities throughout the world, as well as the palliative care option for those who either can not or choose not to be treated. Every year, progress is being made.

 
Beat Mesothelioma is a site created to provide you with up to date information on the deadly disease Mesothelioma. We endeavour to provide the most complete overview of the disease and all aspects of it. This includes general information on the disease, breaking news on the search for a cure and perspective legislation designed to limit you as well as all other news on the subject, links to other sites and online resources that can provide important and in-depth Mesothelioma and cancer related information, and a legal guide to help you with the complex legal issues involved with Mesothelioma.

Mesothelioma is a disease that is almost 100% preventable; the only known cause is via exposure to the deadly mineral Asbestos. It comes from inhaling the particles of dust as the asbestos degrades; eating away at the lining of your lungs and developing into a deadly cancer. Dust that was inhaled in clouds of white powder, dust that was carried home on the clothes of the men who built this country, dust that was cleaned from the clothes by the wives and children who supported their sole provider at home, dust that was packed around the heating systems in houses and offices and schools, dust that carried a deadly price; and dust made a fortune in blood money for the companies that produced it.

Unfortunately, the effects of asbestos on the human body were known to be deadly for years by the companies who employed the ‘greatest generation’ and made hundreds of millions, if not billions, of dollars off of their backs. But instead of taking the basic steps to solve the problem and save the lives of thousands of their workers, they chose to do nothing and continue to make a “healthy” profit with a “deadly”

product. Many even went so far as to hide the truth from their workers and their families. And because the normal latency period for Mesothelioma (The time from exposure until the patient falls ill) is 20 to 30 years, many got away with this for years. We are only now beginning to see the full effects of the disease, and feel the terrible outcry of the people against those who put profits before human lives to a degree that is simply unfathomable.

Press Release Source: Alfacell Corporation
BLOOMFIELD, N.J., Feb. 27 /PRNewswire-FirstCall/ — Alfacell Corporation (Nasdaq: ACEL - News) today announced that the full enrollment target of 316 patients has been reached for the international, confirmatory Phase IIIb registration trial evaluating ONCONASE® (ranpirnase), the Company’s lead investigational drug candidate, as a treatment for unresectable malignant mesothelioma (UMM).The Company has developed and managed one of the largest UMM clinical programs ever undertaken. Over 600 UMM patients have been enrolled in the ONCONASE UMM study, including newly-diagnosed and refractory patients treated with ONCONASE as a single agent and in combination with doxorubicin.”We are pleased to have achieved this important milestone ahead of schedule, and look forward to completion of all other regulatory requirements for the marketing approval of ONCONASE in the U.S., E.U. and other markets,” stated Kuslima Shogen, Chief Executive Officer of Alfacell.

About the ONCONASE Phase IIIb Registration Study
ONCONASE is being evaluated at over 40 investigator sites across 10 countries in a centrally-randomized, open-label Phase IIIb trial as a treatment for UMM, an asbestos-related cancer that afflicts approximately 10,000 people worldwide — including 4,000 in the U.S. — each year. The study is being conducted to determine whether survival is prolonged in UMM patients treated with ONCONASE in combination with doxorubicin compared to doxorubicin alone. The estimated global UMM market is $300 million.

About ONCONASE
ONCONASE is a first-in-class therapeutic from Alfacell’s proprietary ribonuclease (RNase) technology platform. ONCONASE has been shown to target tumor cells while sparing normal cells. ONCONASE is internalized by endocytosis and released into the cytosol of the cancerous cell, where it selectively degrades tRNA beyond repair. In doing so, ONCONASE inhibits protein synthesis, stops cell cycle proliferation, and induces apoptosis (programmed cell death).ONCONASE has previously been granted Orphan Drug designation from EMEA and TGA (Australia), as well as Fast Track status by the FDA. The latter has enabled the Company to complete and submit sections of the New Drug Application (NDA) on an accelerated, rolling basis.In addition to the Phase IIIb UMM registration trial, the Company is conducting an ONCONASE Phase I / II trial in Non-Small Cell Lung Cancer (NSCLC). The NSCLC market is expected to exceed $4 billion by 2012.Also, pre-clinical studies examining ONCONASE conjugates as potential treatments for gliomas and Non-Hodgkins Lymphoma (NHL) are being conducted at Johns Hopkins University and the National Cancer Institute (NCI), respectively.

According to a report recently published in the New England Journal of Medicine, researchers at Taiwan University have developed a five-gene test that may help show which early-stage lung cancer patients most need chemotherapy. Chemotherapy can be greatly beneficial in slowing or halting the growth of lung cancer in some patients, but have little or no effect in others.

Currently, no test exists to help determine which patients might most benefit from chemotherapy treatments.The genetic test, which is still experimental, needs to be validated in larger groups of patients, and widespread use is likely a few years in the future. Still, researchers are encouraged by the early promise shown by the test, and the fact that its simplicity would make it relatively easy to use in everyday hospital settings.

USGS scientists debunk industry claim, call particles dangerous.
The Sacramento Bee reported on December 20, 2006 that the U.S. Geological Survey confirmed a federal environmental agency’s findings of a particularly dangerous kind of asbestos on playgrounds in El Dorado Hill. USGS experts in mineral identification reached the conclusion after closely examining the playgrounds’ study samples of tiny particles that the mining industry asserted were not asbestos.The U. S. Environmental Protection Agency conducted the October 2004 study of El Dorado Hills’ Community Park and nearby schoolyards, and EPA officials said the Geological Survey’s findings affirmed its pioneering exposure studies of naturally occurring asbestos in El Dorado Hills and elsewhere in the country.The EPA study found that children and adults in El Dorado Hills can significantly raise their exposure to breathable asbestos particles simply from the dust kicked up riding a bicycle or playing basketball on outdoor courts. Asbestos health experts say that the main public health concern related to such exposures is mesothelioma, a cancer of the membranes lining the chest and other body cavities.The findings from federal scientists prompted the Community Services District to blacktop the New York Creek trail running through the park and increase irrigation on sports fields to cut dust.

The County Supervisor of El Dorado Hills, Helen Baumann, called the Geological Survey’s study “a fair analysis” and left her confident that the county is “doing everything we need to do to protect public health.”The USGS investigators said asbestos health experts, not the mining industry or mineralogists, need to take the lead in redefining asbestos from a health perspective. “Ultimately, it is the health community that must determine what particle types are significant with respect to asbestos-related diseases,”the report said.

According to a poll conducted by USA TODAY, Kaiser Family Foundation, and the Harvard School of Public Health, half of cancer patients and their households have trouble coordinating medical care for their disease. The poll, reported in an article appearing in the USA TODAY on November 20, 2006, surveyed 930 adults who had survived cancer in the preceding five years or who share a household with someone diagnosed with cancer. 
According to the USA TODAY article, coordinating care is one of the biggest challenges for cancer patients. Unlike past decades, when patients spent months in the hospital while receiving chemotherapy and other treatments, patients today often receive treatment or attend doctors’ appointments for only a few hours at a time. Cancer care is also more complex than in years past, with patients seeing a variety of doctors who each handle only one facet of patients’ care, often in different offices.

In such cases, unless one doctor takes responsibility for coordinating care, a patient’s medical records may be scattered among various doctors’ offices and treatment may be piecemeal. The problem is compounded by the fact that insurance plans do not typically pay doctors to coordinate care. Patients who attend comprehensive cancer centers may receive better coordination of their care, but only about 10% of cancer patients are treated at this type of large cancer center. Ellen Stovall, president and chief executive officer of the National Coalition for Cancer Survivorship, advocates for improved information for cancer patients. For example, she supports the Comprehensive Cancer Care Improvement Act, which would allow Medicare to pay doctors for coordinating care.

According to Stovall, every cancer patient deserves three key documents: A care plan, developed soon after diagnosis, outlining the patient’s treatment plan;A treatment summary provided to the patient after the conclusion of their therapy, summarizing their surgeries, radiation and drugs, including dosages; A plan for ongoing care, providing guidance for how survivors should monitor their health, including information about screening tests, follow-up exams, and possible long-term side effects of the treatment they received.

By John Council Texas Lawyers Friday, February 9, 2007
In a surprising verdict, a jury in a Dallas federal court found that a former associate with Baron & Budd “deliberately lied” to three clients, awarding them $129,000 in damages on Feb. 8.The case was unusual because the three plaintiffs in Jacobs, et al. v William K. Tapscott Jr., et al. still are current Baron & Budd asbestos clients. Former associate Ken Tapscott recently left Baron & Budd after he was elected judge of Dallas County Court-at-Law No. 4.As U.S.

District Judge Sidney Fitzwater read the jury’s verdict in the case on Thursday evening, Tapscott laughed incredulously and shook his head. The jury found that Tapscott breached his fiduciary duty when he lied to his clients by telling them that all of the asbestos defendants they sued in 1996 had agreed to settle their case when in fact one defendant had not settled.”I did not deliberately lie to anyone,” Tapscott said as he left the Earle Cabell Federal Building.However, the jury found that Dallas-based Baron & Budd did not breach its fiduciary duty to them by abusing the powers of attorney in its employment agreements with the plaintiffs.

Robert Greenberg, a Dallas solo who represents defendants Tapscott and Baron & Budd, believes the jury was wrong and hopes Fitzwater will set aside the jurors’ decision by granting his directed verdict motion that is pending before the court.The plaintiffs are family members of Carl Jacobs, who died in 1996 at age 80 after he was diagnosed with malignant mesothelioma, a deadly lung disease associated with asbestos exposure. Widow Karin Jacobs and Carl’s daughters Patria Jacobs and JoeAnn Frost hired Baron & Budd in 1996 to pursue a wrongful-death case against numerous asbestos defendants.At the trial, which began on Feb. 5, the plaintiffs testified that Tapscott, who was the case manager in their wrongful-death suit, told them on June 1, 1999, that their case had settled for $2.5 million in a Galveston state district court.

They also testified that Tapscott failed to tell them that one of the defendants, the Pittsburgh Corning Corp., rescinded its settlement offer a day later.The plaintiffs testified that Tapscott’s failure to keep them informed about the problems with the settlement offer caused them to lose a trial date in the case and the ability to pursue a verdict against Pittsburgh Corning before the company filed for bankruptcy in 2000. The plaintiffs discovered they had not recovered as much money as they had been promised by Baron & Budd, and they claimed the firm was not responsive to their inquiries about the reasons for the shortfall.Baron & Budd is still pursuing claims against Pittsburgh Corning on behalf of the Jacobs family in a U.S. Bankruptcy Court, according to trial testimony.

Baron & Budd supervising lawyers and Tapscott denied during testimony that they lied to the plaintiffs. Instead, experts testifying for Baron & Budd said the Jacobs family received a reasonable recovery in their wrongful-death case and that therefore the family had not suffered any damages.”It is a just verdict,” Karin Jacobs said after the verdict. “It was the principle of the thing. It didn’t have anything to do with money. We were lied to.

Our phone calls weren’t returned and we had just had enough.”Jeff Lynch, a Dallas solo who represented the Jacobs family in their suit against Baron & Budd and Tapscott, says there is a lesson for lawyers from this litigation.
“You’ve got to be absolutely truthful, candid and straightforward and not hide or conceal anything from your client,” Lynch says. “That is the bottom line.”

USA

A number of medical centers in the U.S. and elsewhere specialize in one or more types of mesothelioma treatment.

This is by no means a complete list of places that provide treatment for mesothelioma. There may well be other centers or hospitals closer to where you live. Be sure to speak with your doctor about recommendations and referrals.

University of Alabama at Birmingham Comprehensive Cancer Center 1824 6th Ave. S., 236 TI Birmingham AL 35294 Tel: 205.934.5077

Arizona Cancer Center 1515 N. Campbell Ave., PO Box 245024 Tucson AZ 85724 Tel:520.626.3434

Cedars-Sinai Medical Center 8700 Beverly Blvd. Los Angeles CA 90048 Tel:310.423.5874

UCLA Thoracic Oncology, Department of Surgery Meso Treatment Section P.O. Box 951741
Los Angeles CA 90095-1741 Tel:310.794.7337

City of Hope Comprehensive Cancer Center City of Hope Comprehensive Cancer Center Duarte CA 91010-3000

University of Colorado Cancer Center 4200 E. 9th Ave., B-158 Denver CO 80262 Tel:303.315.8801

Yale Comprehensive Cancer Center, Department of Therapeutic Radiology, Yale University School of Medicine 333 Cedar Street, PO Box 208040 New Haven CT O6520 Tel:203.785.4163

Yale Comprehensive Cancer Center, Occupational and Environmental Medicine Program, Yale University School of Medicine 135 College St., 3rd Floor New Haven CT 06501-2483 Tel:203.185.5885

Walter Reed Army Medical Center, Hematology/Oncology, Ward 78 6900 General Ave NW Washington DC 20307-5001 Tel:202.782.6751

Iowa Oncology Research Association 1221 Pleasant St. #100 Des Moines IA 50309 Tel:515.282.2921

CCOP-Carle Cancer Center 602 W. University Ave. Urbana IL 61801 Tel:217.383.3010

University of Chicago Cancer Research Center 5841 S, Maryland Ave., MC 1140 Chicago IL 60637-1470

University of Chicago Cancer Research Center Asst. Prof., Hematology/Oncology Sect., Dept. Med., I0226 (MC 2115) Chicago IL 60637 Tel:773.702.0360

Clinical Research, Decatur Memorial Hospital Cancer Care Institute 2300 N. Edward Decatur IL 62526

Louis A. Weiss Memorial Hospital 4646 N. Marine, Urology Center 5-B Chicago IL 60640

Kentuckian Cancer Institute 100 E. Liberty St. #502 Louisville KY 40202 Tel:502.561.8200

Dana Farber Cancer Center Institute & Division of Thoracic Surgery, Brighams & Womens Hospital 75 Francis Street Boston MA O2115 Tel:617.732.6824

Dana Farber Cancer Center Institute 44 Binney St. Boston MA O2115 Tel:617.632.3470

Greenbaum Cancer Center 22 S. Greene St. Baltimore MD 21201 Tel:410.328.2703

National Cancer Center 10 Center Dr, Bldg. 10, Room 2-B07 Bethesda MD 20892 Tel:301.496.2195

VA Medical Center-Togus 1 VA Center Togus ME O4330 Tel:207.623.8411

Barbara Ann Karmanos Cancer Institute 110 East Warren Avenue Detroit MI 48201 Tel:313.745.8746

McAuley Cancer Care Bldg. Room C139 5301 Huron River Dr. Ypsilanti MI 48197 Tel:734.712.1000

University of Minnesota Cancer Center Division of Hematology/Oncology, MMC286 Minneapolis MN 55455 Tel:612.624.5631

Veterans Affairs Medical Center-Minneapolis 1 Veterans Drive Minneapolis MN 55417 612.725.2000

Veterans Affairs Medical Center-Columbia (Truman Memorial) 800 Hospital Drive Columbia MO 65201 Tel:573.814.6000

University Of Mississippi Medical Center, Attn: Cancer Research Registry 2500 N. State St Jackson MS 39216 Tel:601.984.1095

Comprehensive Cancer Center at Wake Forest University Medical Center Boulevard Winston-Salem NC 27157-1082 Tel:336.716.2088

Creighton University Medical Center, Cancer Center-Suite 2321 601 N. 30th Street Omaha NE 68131 Tel:402.280.5009

Norris Cotton Cancer Center 1 Medical Center Dr. Lebanon NH O3756 Tel:603.650.5534

Mayo Clinic Cancer Center 200 1st St. SW Rochester NM 55905 Tel:507.284.2511

Memorial Sloan-Kettering Cancer 1275 York Ave. New York NY 10021 Tel:212.639.2501

Regional Cancer Center 750 E. Adams Syracuse NY 13210 Tel:315.464.8200

Roswell Park Cancer Institute Elm and Carlton Streets Buffalo NY 14263

CCOP-Sooner State 6151 S. Yale #100 Tulsa OK 74136 Tel:918.499.2000

Veterans Affairs Medical Center-Memphis 1030 Jefferson Ave. Memphis TN 38104 Tel:901.523.8990

University of Texas-MD Anderson Cancer Center 1515 Holcombe Blvd, Unit 432 Houston TX 77030 Tel:713.792.6363

Center for Cancer Care 459 Locust Ave. Charlottesville VA 22902 Tel:434.982.8410

MBCCOP-Massey Cancer Center PO Box 980037 Richmond VA 23298-0037 Tel:804.828.0450

Veterans Affairs Medical Center-White River Junction 250 N. Main St. White River Junction VT O5009 Tel:802.295.9363

Surgeons and Oncologists - USA
Mesothelioma Specialists

You will normally have several doctors helping treat different aspects of your mesothelioma, including one or more professionals with specialties such as oncology, thoracic surgery, and pulmonology. Click here for a list of the types of medical specialists you may well have on your thoracic (chest) oncology care team.

Below is a list by state of U.S. physicians who specialize in treating malignant mesothelioma.

David M. Jablons, MD
Assistant Professor of Surgery Chief, General Thoracic Surgery/UCSF Mt. Zion Medical Center, San Francisco, CA
Phone: (415) 885-3882

Robert Cameron, MD
UCLA Medical Center, Los Angeles, CA
Phone: (310) 794-7333

Paul H. Sugarbaker, MD, FACS, FRCS
Director, Surgical Oncology/Washington Cancer Institute, Washington, DC
Phone: (202) 877-3908

Lary A. Robinson, MD
Director, Division of Cardiovascular and Thoracic Surgery Principal Thoracic Surgical Oncologist/H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL
Phone: (813) 972-8412

Stephen C. Yang, MD
Chief, Division of Thoracic Surgery/Associate Professor of Surgery and Oncology/Surgical Director, Lung Transplantation Program/Director, Thoracic Oncology Program/Johns Hopkins Medical Institutions, Baltimore, MD
Phone: (410) 614-3891

David J. Sugarbaker, MD
Chief, Division of Thoracic Surgery/Brigham and Women’s Hospital, Boston, MA Chief, Department of Surgical Services/Dana-Farber Cancer Institute, Boston, MA
Phone: (617) 732-6824

Harvey Pass, MD
Karmanos Cancer Institute, Detroit, MI
Phone: (313) 745-8746

Gregory P. Kalemkerian, MD
Co-Director of Thoracic Oncology/University of Michigan Comprehensive Cancer Center/Ann Arbor, MI
Phone: (734) 936-5281

David H. Harpole, Jr., MD
Associate Professor of Surgery, Thoracic Oncology Program/Assistant
Professor of Pathology, Duke University Medical Center, Durham, NC
Phone: (919) 668-8413

Brian W. Loggie, MD
Professor of Surgery, Creighton University Medical School; Chief, Division of Surgical Oncology; Director of Cancer Center/Creighton University Medical Center, Omaha, NE
Phone: (402) 280-5009

Valerie W. Rusch, FACS
Attending Thoracic Surgeon/Memorial-Sloan Kettering Cancer Center, New York, NY
Phone: (212) 639-5873

Robert N. Taub, MD
Professor of Clinical Medicine, Columbia University College of Physicians and Surgeons/New York Presbyterian Hospital, New York, NY
Phone: (212) 305-4076

Mary Louise L. Keohan, MD
Assistant Professor of Clinical Medicine, Columbia University College of Physicians and Surgeons/New York Presbyterian Hospital, New York, NY
Phone: (212) 305-4076

Roman Perez-Soler, MD
Associate Director of Clinical Oncology/New York University Kaplan Cancer Center, New York, NY
Phone: (212) 263-8043

Daniel Sterman, MD
Assistant Professor, Department of Medicine/University of Pennsylvania Medical Center, Philadelphia, PA
Phone: (215) 614-0984

Joseph S. Friedberg, MD
Chief of Thoracic Surgery, Thomas Jefferson University Hospital, Philadelphia, PA
Phone: (215) 955-8643

Dong M. Shin, MD
Professor of Medicine and Otolaryngology, Department of Medicine, Division of Hematology Oncology, and Co-Director of Head and Neck Cancer Program/University of Pittsburgh Medical Center, Pittsburgh, PA
Phone: (412) 692-4724

W. Roy Smythe, MD
Assistant Surgeon and Assistant Professor of Surgery/Department of Thoracic and Cardiovascular Surgery, The University of Texas M. D. Anderson Cancer Center, Houston, TX

Eric Vallieres, MD
Associate Professor of Surgery, Section of General Thoracic Surgery/University of Washington Medical Center, Seattle, WA
Phone: (206) 598-4477

Typical members of a thoracic (chest) cancer care team

Normally you will have an interdisciplinary team of doctors helping you with your treatment. Below are some of the types of health professionals you may be dealing with:

Pulmonologist - Physician who diagnoses and treats lung disorders.
Thoracic Surgeon - Surgeon (specialties) heart, lungs, esophagus, and mediastinum.
Medical Oncologist - Physician who cares for cancer patients and is an expert with chemotherapy.
Radiation Oncologist - Physician who cares for cancer patients and is an expert with radiation.
Radiologist - Physician who interprets imaging studies (X-rays, CT scans, MRIs, and ultrasound)
Pathologist - Physician who diagnoses abnormal changes in tissues found in biopsies or postmortem examinations.
Thoracic Oncology Nurse Coordinator - Nurse R.N. who is part of the interdisciplinary team that includes a surgeon.
Social Worker - Trained professional who provides counseling and information to help patients deal with their illnesses.
Respiratory Therapist - Trained medical professional who evaluates, treats, and cares for patients with breathing problems.

United Kingdom

David A. Waller, MDGlenfield Hospital Groby Road Leicester Leicestershire LE3 9QP United Kingdom Specialty: Surgery for pleural mesothelioma

Tom Treasure, MD, MS, FRCS Guy’s Hospital St. Thomas’ Street London Greater London SE1 9RT United Kingdom Specialty: Surgery for pleural mesothelioma

Andrew Ritchie, MD, PhD Papworth Hospital Papworth Everard Cambridge Cambridgeshire CB3 8RE United Kingdom Specialty: Surgery for pleural mesothelioma. Dr. Ritchie is a Consultant Cardiothoracic and Transplant Surgeon at Papworth Hospital NHS Trust. He has a specific interest in pleural mesothelioma.

Robin M. Rudd, MA, MD, FRCP54 New Cavendish Street London, W1G 8TQ United Kingdom Specialties: Respiratory oncology, pleural mesothelioma Also at:The London Chest Hospital Bonner Road London Greater London E2 9JX United Kingdom St. Bartholomew’s Hospital West Smithfield London Greater London EC1A 7BE United Kingdom
Dr. Rudd is Co-Director of Bart’s Mesothelioma Research, and is a Consultant in Medical Oncology at St. Bartholomew’s Hospital. He is world renowned as an expert on mesothelioma diagnosis and treatment, as well as lung cancer and other asbestos-related diseases.

Jeremy P.C. Steele, MD, MRCP54 New Cavendish Street London, W1G 8TQ United Kingdom Specialty: Respiratory oncology, pleural mesothelioma
Dr. Steele is Co-Director of Bart’s Mesothelioma Research, and is a Consultant in Medical Oncology at St. Bartholomew’s Hospital, the Royal London Hospital and the London Chest Hospital. He is also a member of the Board of Directors of the International Mesothelioma Interest Group (IMIG) and is chairman of Mesothelioma UK.

Ireland

Kenneth J. O’Byrne, MDSt. James’ Hospital James Street Dublin Ireland Specialty: Oncology
Germany

Dr. med. Erich HeckerKlinikum Bremen-Ost gGmbH Lehrkrankenhaus der Universität Göttingen Züricher Str. 4028325 Bremen Germany Telephone: 0421 4080 – Specialty: Surgery for pleural mesothelioma

Dr. med. Ludger HillejanKlinik für Thorax chirurgie Klinikum St. Georg Krankenhaus St. Raphael Bremer Strasse 3149179 Ostercappeln Germany Specialty: Surgery for pleural mesothelioma.

Dr. med. Herwart MüllerOnkologische Chirurgie Ofenthaler Weg 20D-97762 Hammelburg Germany Speciality: Surgery for peritoneal mesothelioma
Italy

Dr. Marcello DeracoU. O. Melanoma e SarcomaIstituto Nazionale Tumori MilanoVia Venezian, 120133 Milano Italy Specialty: Surgery for peritoneal mesothelioma
Spain

Alberto Gómez Portilla, MD, PhDPoliclinica San José Beato Tomas de Zumarraga, 1001008 - Vitoria Spain Specialty: Surgery for peritoneal mesothelioma
Australia

A. W. (Bill) Musk, MDSir Charles Gairdner Hospital Hospital Avenue Nedlands, Perth, WA 6009 Australia Telephone: 61 8 9346 4528
Dr. Musk is a respiratory physician and epidemiologist with particular interest in occupational respiratory diseases and occupational cancer.
Bruce Robinson, MDSir Charles Gairdner Hospital Hospital Avenue Nedlands, Perth, WA 6009 Australia Telephone: 61 8 9346 2098

Private Practice: Suite 16, Hollywood Specialist Centre Monash Avenue Nedlands, Perth, WA Australia Telephone: 61 8 9346 2098

United Kingdom

Christie Hospital NHS Trust 550 Wilmslow Road Withington Manchester M20 4BX Telephone: 0161 446 3000.  The Christie Hospital NHS Trust is the largest single-site cancer treatment centre in Europe, and offers services incuding diagnosis, treatment and general care for cancer patients, and well as cancer education.

The Royal Marsden Hospital (London) Fulham Road London SW3 6JJ Telephone: 020 7352 8171

The Royal Marsden Hospital (Surrey) Downs Road Sutton Surrey SM2 5PT Telephone: 020 8642 6011

The Royal Marsden, with facilities in London and Surrey, is a leader in the field of innovative new cancer treatments, and the development of new drugs to fight cancer. It is the oldest hospital in the world dedicated to cancer treatment, research and education.

Glenfield Hospital Groby Road Leicester Leicestershire LE3 9QP Telephone: 0116 287 1471

Guy’s Hospital St. Thomas’ Street London SE1 9RT Telephone: 020 7188 7188

The London Chest HospitalBonner RoadLondon E2 9JX Telephone: 020 7377 7000

St. Bartholomew’s Hospital West Smithfield London EC1A 7BE Telephone: 020 7377 7000

Papworth Hospital Papworth Everard Cambridge Cambridgeshire CB3 8RE Telephone: 01480 830541

Ireland

St. James’ Hospital James Street Dublin Ireland Phone: +(353-1) 410 3000

France

Institut Gustave-Roussy39 Rue Camille Desmoulins 94805 Villejuif Cedex France Phone: 00 33 1 42 11 42 11

Germany

Klinikum Bremen-Ost gGmbH Lehrkrankenhaus der Universität Göttingen Züricher Str. 4028325 Bremen Germany Telephone: 0421 408 - 0

Thoraxklinik Heidelberg Amalienstrasse 569126 Heidelberg Germany Telephone: 49 (0)6221 - 396 - 0 The Thoraxklinik, affiliated with the University of Heidelberg, is the largest thoracic disease treatment center in Germany. It offers consultation, diagnostic and treatment services for pleural mesothelioma patients.

Universitätsklinikum Freiburg Hugstetter Strasse 5579106 Freiburg Germany Telephone: 07 61/2 70-0 The German University Hospital at Freiburg focuses on novel diagnostic procedures and treatments, as well applying the latest findings in clinical research. Interdisciplinary specialist teams provide top-quality, personalized medical care.

Klinik für ThoraxchirurgieKlinikum St. Georg Krankenhaus St. Raphael Bremer Strasse 3149179 Ostercappeln Germany Telephone: 05473/ 29 397 For treatment of pleural mesothelioma.

Krankenhaus Hammelburg GmbH Onkologische ChirurgieOfenthaler Weg 20D-97762 Hammelburg Germany Telephone: 49 9732 900156

Italy

U. O. Melanoma e SarcomaIstituto Nazionale Tumori MilanoVia Venezian, 120133 MilanoItalyTelephone: 39 02 76008435

Spain

Policlinica San JoséBeato Tomas de Zumarraga, 1001008 - VitoriaSpainTelephone: 34 945 14 09 00For treatment of peritoneal mesothelioma.

Switzerland

UniversitätsSpital ZürichKlinik für ThoraxchirurgieRämistrasse 100CH - 8091 ZürichSwitzerlandTelephone: 41 44 255 88 02

Australia

Sir Charles Gairdner HospitalHospital AvenueNedlands, Perth, WA 6009AustraliaTelephone: 61 8 9346 3333Peter MacCallum Cancer CentreSt. Andrews PlaceEast Melbourne, Vic 3002AustraliaTelephone: 61 3 9656 1111